Barbara C. Fullerton, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Evoked Potentials, Auditory, Brain Stem | 8 | 2005 | 245 | 0.550 |
Why?
|
| Photons | 7 | 2018 | 597 | 0.450 |
Why?
|
| Auditory Pathways | 6 | 2005 | 233 | 0.330 |
Why?
|
| Radiation Injuries | 6 | 2021 | 1228 | 0.310 |
Why?
|
| Cochlear Nucleus | 2 | 2005 | 61 | 0.280 |
Why?
|
| Inferior Colliculi | 3 | 2005 | 66 | 0.280 |
Why?
|
| Radiotherapy, Conformal | 6 | 2013 | 563 | 0.280 |
Why?
|
| Olivary Nucleus | 2 | 2005 | 130 | 0.270 |
Why?
|
| Brain Stem | 10 | 2000 | 848 | 0.270 |
Why?
|
| Auditory Cortex | 2 | 2007 | 335 | 0.260 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 9 | 2021 | 1568 | 0.250 |
Why?
|
| Meningioma | 3 | 2019 | 1203 | 0.240 |
Why?
|
| Meningeal Neoplasms | 3 | 2019 | 1221 | 0.240 |
Why?
|
| Relative Biological Effectiveness | 2 | 2021 | 344 | 0.220 |
Why?
|
| Temporal Lobe | 2 | 2007 | 1655 | 0.210 |
Why?
|
| Cranial Irradiation | 3 | 2019 | 435 | 0.200 |
Why?
|
| Radiotherapy, Intensity-Modulated | 4 | 2021 | 782 | 0.190 |
Why?
|
| Lymphoma, Extranodal NK-T-Cell | 1 | 2019 | 46 | 0.180 |
Why?
|
| Radiotherapy Dosage | 11 | 2021 | 2927 | 0.180 |
Why?
|
| Neuroma, Acoustic | 1 | 2022 | 445 | 0.170 |
Why?
|
| Neurosecretory Systems | 1 | 2019 | 238 | 0.160 |
Why?
|
| Optic Nerve | 2 | 2018 | 558 | 0.160 |
Why?
|
| Hypopituitarism | 1 | 2019 | 258 | 0.160 |
Why?
|
| Glioma | 3 | 2019 | 3292 | 0.160 |
Why?
|
| Protons | 3 | 2022 | 1047 | 0.150 |
Why?
|
| Chondrosarcoma | 5 | 2018 | 296 | 0.140 |
Why?
|
| Optic Nerve Diseases | 1 | 2018 | 320 | 0.140 |
Why?
|
| Supratentorial Neoplasms | 2 | 2013 | 158 | 0.140 |
Why?
|
| Hearing Loss | 1 | 2022 | 711 | 0.140 |
Why?
|
| Organs at Risk | 2 | 2018 | 333 | 0.130 |
Why?
|
| Cerebellar Neoplasms | 2 | 2013 | 601 | 0.130 |
Why?
|
| Brain Neoplasms | 5 | 2019 | 8776 | 0.130 |
Why?
|
| Medulloblastoma | 2 | 2013 | 715 | 0.120 |
Why?
|
| Auditory Perception | 6 | 1998 | 516 | 0.120 |
Why?
|
| Radiosurgery | 1 | 2022 | 1352 | 0.120 |
Why?
|
| Pituitary Neoplasms | 1 | 2021 | 1287 | 0.120 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2013 | 142 | 0.110 |
Why?
|
| Chordoma | 4 | 2018 | 388 | 0.110 |
Why?
|
| Cats | 4 | 1996 | 1041 | 0.110 |
Why?
|
| Rhabdoid Tumor | 1 | 2013 | 210 | 0.100 |
Why?
|
| Skull Base Neoplasms | 3 | 2001 | 278 | 0.100 |
Why?
|
| Pituitary Gland | 3 | 2019 | 667 | 0.100 |
Why?
|
| Memory Disorders | 1 | 2018 | 1139 | 0.100 |
Why?
|
| Teratoma | 1 | 2013 | 385 | 0.100 |
Why?
|
| Radiation Tolerance | 2 | 2018 | 509 | 0.090 |
Why?
|
| Pons | 4 | 2000 | 252 | 0.090 |
Why?
|
| Multiple Sclerosis | 6 | 2000 | 2934 | 0.080 |
Why?
|
| Postmortem Changes | 1 | 2007 | 129 | 0.080 |
Why?
|
| Sound Localization | 2 | 2000 | 60 | 0.080 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2012 | 565 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2017 | 8877 | 0.080 |
Why?
|
| Macaca | 1 | 2007 | 450 | 0.070 |
Why?
|
| Cauda Equina | 1 | 2005 | 48 | 0.070 |
Why?
|
| Acoustic Stimulation | 4 | 2005 | 1191 | 0.070 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2010 | 475 | 0.070 |
Why?
|
| Hippocampus | 1 | 2018 | 3639 | 0.070 |
Why?
|
| Ependymoma | 1 | 2008 | 324 | 0.070 |
Why?
|
| Skull Neoplasms | 2 | 2018 | 177 | 0.070 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2013 | 865 | 0.070 |
Why?
|
| Neoplasms, Second Primary | 1 | 2012 | 985 | 0.060 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1987 | 516 | 0.060 |
Why?
|
| Noise | 1 | 2005 | 267 | 0.060 |
Why?
|
| Staining and Labeling | 1 | 2007 | 1151 | 0.060 |
Why?
|
| Orbital Neoplasms | 1 | 2005 | 247 | 0.060 |
Why?
|
| Male | 29 | 2021 | 349524 | 0.060 |
Why?
|
| Adult | 22 | 2022 | 211041 | 0.060 |
Why?
|
| Functional Laterality | 2 | 2007 | 2296 | 0.060 |
Why?
|
| Rhabdomyosarcoma | 1 | 2005 | 381 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2005 | 34151 | 0.050 |
Why?
|
| Cognition | 2 | 2018 | 5982 | 0.050 |
Why?
|
| Female | 28 | 2021 | 375205 | 0.050 |
Why?
|
| Radiometry | 2 | 2018 | 823 | 0.050 |
Why?
|
| Ear | 1 | 2000 | 180 | 0.050 |
Why?
|
| Disease-Free Survival | 3 | 2017 | 7026 | 0.050 |
Why?
|
| Prospective Studies | 7 | 2022 | 50597 | 0.050 |
Why?
|
| Brain | 5 | 2021 | 24969 | 0.050 |
Why?
|
| Humans | 36 | 2022 | 708843 | 0.040 |
Why?
|
| Treatment Outcome | 7 | 2022 | 61932 | 0.040 |
Why?
|
| Infratentorial Neoplasms | 2 | 2013 | 99 | 0.040 |
Why?
|
| Hearing | 1 | 2022 | 429 | 0.040 |
Why?
|
| Moyamoya Disease | 1 | 2021 | 224 | 0.040 |
Why?
|
| Craniopharyngioma | 1 | 2021 | 278 | 0.040 |
Why?
|
| Thyroid Function Tests | 1 | 2019 | 289 | 0.040 |
Why?
|
| Child, Preschool | 7 | 2021 | 41081 | 0.040 |
Why?
|
| Nausea | 1 | 2021 | 654 | 0.040 |
Why?
|
| Vomiting | 1 | 2021 | 626 | 0.040 |
Why?
|
| Brain Mapping | 2 | 2007 | 6545 | 0.040 |
Why?
|
| Follow-Up Studies | 5 | 2022 | 39038 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2017 | 423 | 0.040 |
Why?
|
| Kainic Acid | 1 | 1996 | 204 | 0.040 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 1996 | 160 | 0.040 |
Why?
|
| Dose-Response Relationship, Radiation | 3 | 2008 | 919 | 0.040 |
Why?
|
| Mental Processes | 1 | 1997 | 251 | 0.040 |
Why?
|
| Adolescent | 10 | 2021 | 84718 | 0.040 |
Why?
|
| Monte Carlo Method | 1 | 2021 | 1301 | 0.040 |
Why?
|
| Retrospective Studies | 7 | 2022 | 71483 | 0.030 |
Why?
|
| Hypothalamus | 1 | 2001 | 1063 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2021 | 1906 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 2000 | 1039 | 0.030 |
Why?
|
| Aged | 10 | 2019 | 161488 | 0.030 |
Why?
|
| Middle Aged | 16 | 2019 | 213752 | 0.030 |
Why?
|
| Infant | 5 | 2021 | 34261 | 0.030 |
Why?
|
| Fatigue | 1 | 2021 | 1450 | 0.030 |
Why?
|
| Headache | 1 | 2021 | 1109 | 0.030 |
Why?
|
| Vision Disorders | 1 | 2021 | 1038 | 0.030 |
Why?
|
| Echo-Planar Imaging | 1 | 1998 | 664 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2005 | 12447 | 0.030 |
Why?
|
| Chondroma | 1 | 1992 | 60 | 0.030 |
Why?
|
| Cranial Nerves | 1 | 1992 | 97 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 1998 | 1508 | 0.030 |
Why?
|
| Child | 7 | 2021 | 73636 | 0.030 |
Why?
|
| Radiotherapy, High-Energy | 1 | 1992 | 244 | 0.030 |
Why?
|
| Endocrine System Diseases | 1 | 2013 | 247 | 0.030 |
Why?
|
| Germinoma | 1 | 2010 | 139 | 0.020 |
Why?
|
| Young Adult | 4 | 2021 | 55940 | 0.020 |
Why?
|
| Cochlear Nerve | 1 | 1990 | 194 | 0.020 |
Why?
|
| Reaction Time | 3 | 1998 | 2134 | 0.020 |
Why?
|
| Memory | 1 | 2018 | 2154 | 0.020 |
Why?
|
| Cochlea | 2 | 2012 | 782 | 0.020 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2013 | 774 | 0.020 |
Why?
|
| Electrophysiology | 3 | 1996 | 1329 | 0.020 |
Why?
|
| Survival Rate | 3 | 2010 | 13202 | 0.020 |
Why?
|
| Body Height | 1 | 2013 | 1587 | 0.020 |
Why?
|
| Quality of Life | 2 | 2019 | 11594 | 0.020 |
Why?
|
| Stapedius | 1 | 1985 | 25 | 0.020 |
Why?
|
| Actuarial Analysis | 1 | 2005 | 385 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 6879 | 0.020 |
Why?
|
| Psychoacoustics | 2 | 1995 | 58 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 3515 | 0.020 |
Why?
|
| Prognosis | 2 | 2019 | 28919 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 1998 | 3260 | 0.020 |
Why?
|
| Animals | 7 | 2007 | 170486 | 0.020 |
Why?
|
| Auditory Threshold | 2 | 1995 | 352 | 0.010 |
Why?
|
| Cause of Death | 1 | 2013 | 3497 | 0.010 |
Why?
|
| Facial Nerve | 1 | 1985 | 275 | 0.010 |
Why?
|
| Species Specificity | 1 | 1987 | 2619 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13298 | 0.010 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2005 | 337 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2008 | 2680 | 0.010 |
Why?
|
| Neurons | 2 | 1996 | 9385 | 0.010 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 58184 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 20320 | 0.010 |
Why?
|
| Hyperprolactinemia | 1 | 2001 | 133 | 0.010 |
Why?
|
| Motor Neurons | 1 | 1985 | 815 | 0.010 |
Why?
|
| Muscles | 1 | 1985 | 1622 | 0.010 |
Why?
|
| Fetal Hypoxia | 1 | 1979 | 31 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1987 | 1565 | 0.010 |
Why?
|
| Dichotic Listening Tests | 1 | 1998 | 22 | 0.010 |
Why?
|
| Risk | 1 | 2012 | 9641 | 0.010 |
Why?
|
| Asphyxia Neonatorum | 1 | 1979 | 106 | 0.010 |
Why?
|
| Spinal Neoplasms | 1 | 2005 | 837 | 0.010 |
Why?
|
| Discrimination Learning | 1 | 1979 | 296 | 0.010 |
Why?
|
| Nissl Bodies | 1 | 1996 | 18 | 0.010 |
Why?
|
| Neuropsychology | 1 | 1997 | 106 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2005 | 6530 | 0.010 |
Why?
|
| Hypothyroidism | 1 | 2001 | 650 | 0.010 |
Why?
|
| Stroke | 1 | 2017 | 9256 | 0.010 |
Why?
|
| Hypogonadism | 1 | 2001 | 753 | 0.010 |
Why?
|
| Time Factors | 1 | 2017 | 41038 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2013 | 24433 | 0.010 |
Why?
|
| Audiometry | 1 | 1995 | 249 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2004 | 4883 | 0.010 |
Why?
|
| Axons | 2 | 1996 | 1747 | 0.010 |
Why?
|
| Cranial Nerve Injuries | 1 | 1992 | 26 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 69553 | 0.010 |
Why?
|
| Speech Perception | 1 | 1994 | 445 | 0.010 |
Why?
|
| Reference Values | 1 | 1998 | 5041 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 13714 | 0.010 |
Why?
|
| Cricetinae | 1 | 1993 | 2588 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1997 | 1938 | 0.010 |
Why?
|
| Learning | 1 | 1997 | 1596 | 0.010 |
Why?
|
| Heart Rate | 1 | 1998 | 4094 | 0.000 |
Why?
|
| Models, Neurological | 1 | 1995 | 1770 | 0.000 |
Why?
|
| Chorda Tympani Nerve | 1 | 1985 | 15 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1998 | 8896 | 0.000 |
Why?
|
| Nerve Endings | 1 | 1983 | 113 | 0.000 |
Why?
|
| Vagus Nerve | 1 | 1985 | 444 | 0.000 |
Why?
|
| Cell Count | 1 | 1985 | 1920 | 0.000 |
Why?
|
| Nerve Fibers | 1 | 1983 | 713 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1983 | 2881 | 0.000 |
Why?
|
| Haplorhini | 1 | 1979 | 582 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2001 | 20308 | 0.000 |
Why?
|
| Synapses | 1 | 1983 | 1706 | 0.000 |
Why?
|
| Evoked Potentials | 1 | 1979 | 1031 | 0.000 |
Why?
|
| Macaca mulatta | 1 | 1979 | 2427 | 0.000 |
Why?
|
| Pregnancy | 1 | 1979 | 26832 | 0.000 |
Why?
|